
Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents
Author(s) -
Dirk Walter,
Manfred Cejna,
Larry J. DíazSandoval,
Sean L. Willis,
Laura C Kirkwood,
Peter W. Stratford,
Anne Barbara Tietz,
Rudolf Kirchmair,
Marcy Silver,
Cindy Curry,
Andrea Wecker,
Youngsup Yoon,
Regina Heidenreich,
Allison Hanley,
Marianne Kearney,
Fermin O. Tio,
Patrik Kuenzler,
Jeffrey M. Isner,
Douglas W. Losordo
Publication year - 2004
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.0000133324.38115.0a
Subject(s) - medicine , gene transfer , plasmid , gene , genetic enhancement , cardiology , genetics , biology
Drug-eluting stents represent a useful strategy for the prevention of restenosis using various antiproliferative drugs. These strategies share the liability of impairing endothelial recovery, thereby altering the natural biology of the vessel wall and increasing the associated risk of stent thrombosis. Accordingly, we tested the hypothesis that local delivery via gene-eluting stent of naked plasmid DNA encoding for human vascular endothelial growth factor (VEGF)-2 could achieve similar reductions in neointima formation while accelerating, rather than inhibiting, reendothelialization.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom